TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Ward, E. PY - 2008 DA - 2008// TI - Cancer statistics JO - Cancer Journal for Clinicians VL - 58 UR - https://doi.org/10.3322/CA.2007.0010 DO - 10.3322/CA.2007.0010 ID - Jemal2008 ER - TY - JOUR AU - Breedlove, G. AU - Busenhart, C. PY - 2005 DA - 2005// TI - Screening and detection of ovarian cancer JO - Journal of Midwifery & Women's Health VL - 50 UR - https://doi.org/10.1016/j.jmwh.2004.10.002 DO - 10.1016/j.jmwh.2004.10.002 ID - Breedlove2005 ER - TY - JOUR AU - Bast, R. C. AU - Hennessy, B. AU - Mills, G. B. PY - 2009 DA - 2009// TI - The biology of ovarian cancer: new opportunities for translation JO - Nature Reviews Cancer VL - 9 UR - https://doi.org/10.1038/nrc2644 DO - 10.1038/nrc2644 ID - Bast2009 ER - TY - JOUR AU - Carpenter, G. PY - 1987 DA - 1987// TI - Receptors for epidermal growth factor and other polypeptide mitogens JO - Annu Rev Biochem VL - 56 UR - https://doi.org/10.1146/annurev.bi.56.070187.004313 DO - 10.1146/annurev.bi.56.070187.004313 ID - Carpenter1987 ER - TY - JOUR AU - Coussens, L. AU - Yang-Feng, T. L. AU - Liao, Y. C. PY - 1985 DA - 1985// TI - Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene JO - Science VL - 230 UR - https://doi.org/10.1126/science.2999974 DO - 10.1126/science.2999974 ID - Coussens1985 ER - TY - JOUR AU - Popescu, N. C. AU - King, C. R. AU - Kraus, M. H. PY - 1989 DA - 1989// TI - Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32 JO - Genomics VL - 4 UR - https://doi.org/10.1016/0888-7543(89)90343-1 DO - 10.1016/0888-7543(89)90343-1 ID - Popescu1989 ER - TY - JOUR AU - Yarden, Y. AU - Sliwkowski, M. X. PY - 2001 DA - 2001// TI - Untangling the ErbB signalling network JO - Nat Rev Mol Cell Biol VL - 2 UR - https://doi.org/10.1038/35052073 DO - 10.1038/35052073 ID - Yarden2001 ER - TY - JOUR AU - Slamon, D. J. AU - Godolphin, W. AU - Jones, L. A. PY - 1989 DA - 1989// TI - Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer JO - Science VL - 244 UR - https://doi.org/10.1126/science.2470152 DO - 10.1126/science.2470152 ID - Slamon1989 ER - TY - JOUR AU - Verri, E. AU - Guglielmini, P. AU - Puntoni, M. PY - 2005 DA - 2005// TI - HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance JO - Oncology VL - 68 UR - https://doi.org/10.1159/000086958 DO - 10.1159/000086958 ID - Verri2005 ER - TY - JOUR AU - Cheng, J. D. AU - Rieger, P. T. AU - von Mehren, M. PY - 2000 DA - 2000// TI - Recent advances in immunotherapy and monoclonal antibody treatment of cancer JO - Semin Oncol Nurs VL - 16 UR - https://doi.org/10.1053/sonu.2000.19775 DO - 10.1053/sonu.2000.19775 ID - Cheng2000 ER - TY - JOUR AU - Bell, R. i. c. h. a. r. d. PY - 2002 DA - 2002// TI - What Can We Learn from Herceptin Trials in Metastatic Breast Cancer? JO - Oncology VL - 63 UR - https://doi.org/10.1159/000066200 DO - 10.1159/000066200 ID - Bell2002 ER - TY - JOUR AU - Cuello, M. a. u. r. i. c. i. o. AU - Seth, A. AU - Ettenberg AU - Amy, S. PY - 2001 DA - 2001// TI - Down-Regulation of the erbB-2 Receptor by Trastuzumab (Herceptin) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Breast and Ovarian Cancer Cell Lines that Overexpress erbB-2 JO - Cancer Res VL - 61 ID - Cuello2001 ER - TY - JOUR AU - Cho, H. S. AU - Mason, K. AU - Ramyar, K. X. PY - 2003 DA - 2003// TI - Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab JO - Nature VL - 421 UR - https://doi.org/10.1038/nature01392 DO - 10.1038/nature01392 ID - Cho2003 ER - TY - JOUR AU - Fujimura, M. AU - Katsumata, N. AU - Tsuda, H. PY - 2002 DA - 2002// TI - HER2 Is Frequently Over-expressed in Ovarian Clear Cell Adenocarcinoma: Possible Novel Treatment Modality Using Recombinant Monoclonal Antibody against HER2, Trastuzumab JO - Jpn J Cancer Res VL - 93 UR - https://doi.org/10.1111/j.1349-7006.2002.tb01231.x DO - 10.1111/j.1349-7006.2002.tb01231.x ID - Fujimura2002 ER - TY - JOUR AU - Dean-Colomb, W. AU - Esteva, F. J. PY - 2008 DA - 2008// TI - Her2-positive breast cancer: herceptin and beyond JO - Eur J Cancer VL - 44 UR - https://doi.org/10.1016/j.ejca.2008.09.013 DO - 10.1016/j.ejca.2008.09.013 ID - Dean-Colomb2008 ER - TY - JOUR AU - Cheng, L. S. AU - Liu, A. P. AU - Yang, J. H. PY - 2003 DA - 2003// TI - Construction, expression and characterization of the engineered antibody against tumor surface antigen, p185(c-erbB-2) JO - Cell Res VL - 13 UR - https://doi.org/10.1038/sj.cr.7290149 DO - 10.1038/sj.cr.7290149 ID - Cheng2003 ER - TY - JOUR AU - Wang, J. i. n. g. AU - Shi, Y. u. AU - Liu, Y. a. n. q. i. PY - 2005 DA - 2005// TI - Purification and characterization of a single-chain chimeric anti-p185 antibody expressed by CHO-GS system JO - Protein expression and purification VL - 41 UR - https://doi.org/10.1016/j.pep.2004.11.007 DO - 10.1016/j.pep.2004.11.007 ID - Wang2005 ER - TY - JOUR AU - Hu, S. AU - Zhu, Z. AU - Li, L. PY - 2008 DA - 2008// TI - Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism JO - Proteins VL - 70 UR - https://doi.org/10.1002/prot.21551 DO - 10.1002/prot.21551 ID - Hu2008 ER - TY - JOUR AU - Wang, C. AU - Li, Y. AU - Li, P. PY - 2000 DA - 2000// TI - Generation and Characterization of monoclonal antibodies specific for the oncogene product P185neu/c-erbB-2 by surface epitope masking (SEM) JO - J Chin Immunol VL - 16 ID - Wang2000 ER - TY - JOUR AU - Ping, L. I. AU - Yun, L. I. AU - Chen, W. a. n. g. PY - 2002 DA - 2002// TI - Investigation on the anti-cancer activities of anti-p185 monoclonal antibodies in vitro JO - Chin Immunol VL - 18 ID - Ping2002 ER - TY - JOUR AU - Steffen, A. C. AU - Göstring, L. AU - Tolmachev, V. PY - 2008 DA - 2008// TI - Differences in radiosensitivity between three HER2 overexpressing cell lines JO - Eur J Nucl Med Mol I VL - 35 UR - https://doi.org/10.1007/s00259-007-0713-x DO - 10.1007/s00259-007-0713-x ID - Steffen2008 ER - TY - JOUR AU - Sujun, L. AU - Xun, L. AU - Daxu, L. PY - 2006 DA - 2006// TI - Tumor inhibition and improved immunity in mice treated with flavone from Cirsium japonicum DC JO - International Immunopharmacology VL - 6 UR - https://doi.org/10.1016/j.intimp.2006.02.002 DO - 10.1016/j.intimp.2006.02.002 ID - Sujun2006 ER - TY - JOUR AU - Jackson, J. G. AU - St Clair, P. AU - Sliwkowski, M. X. PY - 2004 DA - 2004// TI - Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-3106 DO - 10.1158/0008-5472.CAN-03-3106 ID - Jackson2004 ER - TY - JOUR AU - Vogel, C. L. AU - Cobleigh, M. A. AU - Tripathy, D. PY - 2002 DA - 2002// TI - Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.20.3.719 DO - 10.1200/JCO.20.3.719 ID - Vogel2002 ER - TY - JOUR AU - Perez, E. A. PY - 2008 DA - 2008// TI - Cardiac toxicity of ErbB2-targeted therapies: what do we know? JO - Clin Breast Cancer VL - 8 UR - https://doi.org/10.3816/CBC.2008.s.007 DO - 10.3816/CBC.2008.s.007 ID - Perez2008 ER - TY - JOUR AU - Hattori, K. AU - Nishi, Y. AU - Nakamura, S. PY - 2007 DA - 2007// TI - Evaluation of cardiac dysfunction after herceptin treatment in patients with metastatic breast cancer by echocardiography JO - Rinsho Byori VL - 55 ID - Hattori2007 ER - TY - JOUR AU - Vahid, B. AU - Marik, P. E. PY - 2008 DA - 2008// TI - Pulmonary complications of novel antineoplastic agents for solid tumors JO - Chest VL - 133 UR - https://doi.org/10.1378/chest.07-0851 DO - 10.1378/chest.07-0851 ID - Vahid2008 ER - TY - JOUR AU - Slamon, D. J. AU - Leyland-Jones, B. PY - 2001 DA - 2001// TI - Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103153441101 DO - 10.1056/NEJM200103153441101 ID - Slamon2001 ER - TY - JOUR AU - Calabrich, A. AU - Fernandes Gdos, S. AU - Katz, A. PY - 2008 DA - 2008// TI - Trastuzumab: mechanisms of resistance and therapeutic opportunities JO - Oncology (Williston Park) VL - 22 ID - Calabrich2008 ER - TY - JOUR AU - Chen, M. H. PY - 2009 DA - 2009// TI - Cardiac dysfunction induced by novel targeted anticancer therapy: an emerging issue JO - Curr Cardiol Rep VL - 11 UR - https://doi.org/10.1007/s11886-009-0025-9 DO - 10.1007/s11886-009-0025-9 ID - Chen2009 ER - TY - JOUR AU - Wang, J. N. AU - Feng, J. N. AU - Yua, M. PY - 2004 DA - 2004// TI - Structural analysis of the epitopes on erbB2 interacted with inhibitory or non-inhibitor monoclonal antibodies JO - Mol Immu nol VL - 40 UR - https://doi.org/10.1016/j.molimm.2003.09.012 DO - 10.1016/j.molimm.2003.09.012 ID - Wang2004 ER - TY - JOUR AU - Tortora, G. AU - di Isernia, G. AU - Sandomenico, C. PY - 1997 DA - 1997// TI - Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells JO - Cancer Res VL - 57 ID - Tortora1997 ER - TY - JOUR AU - Cummings, M. C. AU - Winterford, C. M. AU - Walker, N. L. PY - 1997 DA - 1997// TI - Apoptosis JO - Am J Surg Pathol VL - 21 UR - https://doi.org/10.1097/00000478-199701000-00010 DO - 10.1097/00000478-199701000-00010 ID - Cummings1997 ER - TY - JOUR AU - Gillardon, F. AU - Wickert, H. AU - Zimmermann, M. PY - 1995 DA - 1995// TI - Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain JO - Neurosci Lett VL - 192 UR - https://doi.org/10.1016/0304-3940(95)11619-8 DO - 10.1016/0304-3940(95)11619-8 ID - Gillardon1995 ER - TY - JOUR AU - Adams, J. M. AU - Cory, S. PY - 1998 DA - 1998// TI - The bcl-2 protein family: arbiters of cell surival JO - Science VL - 281 UR - https://doi.org/10.1126/science.281.5381.1322 DO - 10.1126/science.281.5381.1322 ID - Adams1998 ER - TY - JOUR AU - Rakesh, K. AU - Mahitosh, M. AU - Allan, L. PY - 1996 DA - 1996// TI - Overexpression of HER2 Modulates Bcl-2, Bcl-XL, and Tamoxifen-induced Apoptosis in Human MCF-7 Breast Cancer Cells JO - Clin Cancer Res VL - 2 ID - Rakesh1996 ER - TY - JOUR AU - Zheng, L. AU - Weiya, X. AU - BingLiang, F. PY - 2001 DA - 2001// TI - Targeting HER-2/neu-overexpressing breast cancer cells by an antisense iron responsive element-directed gene expression JO - Cancer lett VL - 174 UR - https://doi.org/10.1016/S0304-3835(01)00700-5 DO - 10.1016/S0304-3835(01)00700-5 ID - Zheng2001 ER -